一个设计用于加强的程序角膜在Lasik叫Lasik XTra之后，已收到欧洲营销的CE批准，并在加拿大批准。

Marketed by Avedro, Inc., Lasik Xtra is an accelerated corneal crosslinking procedure that applies Avedro’s VibeX riboflavin ophthalmic solution to the cornea, and then uses it’s KXL System to irradiate the cornea with UV-A rays that only takes two minutes to apply, making it a good solution to combine with LASIK. Avedro said their studies show the procedure has helped people who received hyperopic LASIK, which tends to regress more than myopic LASIK, and will help patients maintain their vision correction they received from LASIK. Allaboutvision.com

虽然角膜交联尚未获得FDA批准，但Avedro的VIBEX解决方案已收到原子能机构的孤儿药物批准。在这种情况下，孤儿药物状态通常赋予稀有医疗条件的治疗方法，角蛋白，这是角膜逐渐变薄。

有关最新的眼科设备的更多信息，以帮助您的练习扩展在LaserLocat华体会app信誉好华体会体育app官网下载ors.com上联系我们，我们的行业专家提供帮助。